USA
Analytical Standards
Controlled Research Environment
Research Product
CJC-1295
1. Product Overview
CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analogue that has attracted significant scientific interest in research involving endocrine signaling, growth hormone regulation, peptide receptor interactions, and metabolic pathways. Ongoing studies continue to explore its interaction with growth hormone-related biological processes and peptide-mediated signaling mechanisms. CJC-1295 is supplied as a lyophilized research peptide and undergoes analytical testing to verify identity, purity, and consistency.
Manufactured in a controlled research environment, this product is intended exclusively for laboratory and scientific research applications.
2. Specifications
| Product Name | CJC-1295 | Testing Method | HPLC |
|---|---|---|---|
| Synonym | CJC-1295 | Storage Condition | 2-8C |
| Format | Lyophilized Powder | Shelf Life | 24 Months |
| Content | 5 mg | Manufacturing Standard | GMP Standard Research Environment |
| Purity | >=99% HPLC | Country of Origin | USA |
| Appearance | White to Off White Lyophilized Powder | Intended Use | Research Use Only |
3. Research Summary
CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analogue that has attracted significant scientific interest in studies involving endocrine signaling, peptide receptor interactions, growth hormone regulation, metabolic pathways, and neuroendocrine communication mechanisms. Research has explored its interaction with growth hormone-releasing hormone receptors and associated biological signaling networks.
Preclinical and clinical investigations have evaluated CJC-1295 in research involving growth hormone-related biological processes, endocrine regulation, metabolic function, and peptide-mediated cellular communication. Ongoing laboratory studies continue to examine its activity within growth hormone signaling pathways and broader endocrine research applications.
4. Scientific References
- Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA. Prolonged stimulation of growth hormone secretion by CJC-1295. Journal of Clinical Endocrinology & Metabolism. 2006;91(3):799-805.
- Jette L, Leger R, Thibaudeau K, et al. Human growth hormone releasing factor analogue (CJC-1295) studies in endocrine research. Growth Hormone & IGF Research. 2005;15(6):367-377.
- Thorner MO, Chapman IM, Gaylinn BD, Pezzoli SS, Hartman ML. Growth hormone-releasing hormone and growth hormone secretagogues in research and clinical investigation. Endocrine Reviews. 1997;18(5):621-645.
- Bowers CY. Growth hormone-releasing hormone analogues and endocrine regulation. Endocrine. 1998;8(1):7-11.
- Vance ML, Kaiser DL, Frohman LA. Regulation of growth hormone secretion by growth hormone-releasing hormone. Endocrine Reviews. 1985;6(3):389-430.
Disclaimer: This product is intended strictly for research use only. It is not intended for human consumption, clinical application, diagnostic procedures, therapeutic use, veterinary use, or household use. The information provided is for scientific and educational reference purposes only and should not be interpreted as medical advice, treatment guidance, or usage instructions. This product should be handled only by qualified professionals trained in laboratory practices. Purchasers and end users are solely responsible for ensuring compliance with all applicable laws, regulations, and institutional requirements governing the purchase, storage, handling, and use of research materials.
